Authors
Latest:
The Future of Melanoma TreatmentDrugs currently approved by the FDA for treatment of melanoma include aldesleukin, dabrafenib, dacarbazine, ipilimumab, trametinib, and vemurafenib. This article will explore pharmacologic agents currently being investigated for the treatment of melanoma.
Latest:
FDA Says Simvastatin & Ezetimibe Unlikely to Cause CancerThe FDA concludes that the cholesterol-lowering drugs simvastatin (Zocor),ezetimibe (Zetia), and Vytorin (ezetimibe/simvastatin) are not likely to increase cancer risk.
Latest:
Get Connected with Online Physician ConsultationsHow does today's connected, "always on" world translate to your medical practice?
Latest:
Are You Losing Your Voice?Is the rising chorus of online opinion good for you and your patients?
Latest:
The Academy: March 2007The Academy delivers the latest news on biotech and oncology research, providing a link between the clinical world of cancer care and the university researchers who are pushing the envelope of knowledge and discovery.
Latest:
From Pronouncement to Partnership: Understanding New Modes of Communication in a Changing Healthcare SystemThe dramatic change in healthcare delivery from private practitioner-based to managed care created a vacuum of responsibility for self care that the patient has needed to fill.
Latest:
Study Seeks to Eliminate Clinical Barriers to Bone Marrow TransplantsPaul V. O'Donnell, MD, PhD, from the Seattle Cancer Care Alliance, discusses a study examining alternative donor transplant methods for patients with hematologic malignancies.
Latest:
Advances in the Management of Hepatic and Pancreatic MalignanciesPerry Shen, MD, FACS, and Clancy Clark, MD, from Wake Forest Baptist Health Comprehensive Cancer Center, discuss advances in the management of hepatic and pancreatic malignancies.
Latest:
Trial for Anti-Lung Cancer Compound ASA404 Progresses to Phase IIIA pivotal phase III study is currently underway to evaluate the efficacy and safety of Novartis' novel anti-cancer compound ASA404 in patients with non–small cell lung cancer (NSCLC). NSCLC is the most prevalent cause of cancer death among men and women in the United States and globally.
Latest:
How Is Treatment Changing for Patients With Cervical Cancer? Three Experts Weigh InDr. Richard T. Penson, Dr. Bradley J. Monk, and Dr. Krishnansu S. Tewari discuss the evolution of cervical cancer treatment over the past five years.
Latest:
The Industry Insider: March 2007Additional breaking news from the biotech industry. In this issue: 1) FDA OKs Ikonisys' Bladder Cancer Test 2) Good News From China for Peregrine 3) Introgen Sees Advances on Two Fronts 4) Debiopharm Procures Cancer Therapy from Kirin Brewery
Latest:
The Industry Insider: April 2007Companies in the news: 1) AVAX and CTCA Collaborating for Cancer Therapies 2) Full Speed Ahead for GPC Biotech's Satraplatin 3) Bristol-Myers Squibb Company / Adnexus Therapeutics: Collaboration for New Oncology Compounds, and more
Latest:
The Industry Insider: May 2007News and information from the pharmaceutical industry. In this issue: 1) Multiple Deals for Affitech 2) Pfizer%u2019s Sutent Wins European Association of Urology Support 3) Aurora Breast MRI Will Meet Surge in Screening Demand, and more
Latest:
The A-Z Business WireThe latest business and financial biotech news. In this issue: 1) Adherex Buys Back GSK%u2019s Rights to Failed Cancer Drug 2) Archemix and Merck Partner on Aptamer-Based Cancer Therapeutics, and more
Latest:
The Academy: April 2007The Academy delivers the latest news on biotechnology and oncology research, providing a link between the clinical world of cancer care and the university researchers who are pushing farther into knowledge and discovery.
Latest:
News Reports: May 2007News items featured in this month's issue: 1) Preventive Health Exams May Lead to Cancer Screenings by Prachi Patel-Predd 2) Canine Cancer Vaccine Being Investigated for Use in Humans by Diane West 3) Antirejection Drug Shows Promise In Preventing Lung Cancer in Smokers by Diane West, and more
Latest:
Can Mouse Avatars Guide Cancer Treatment?For patients battling a disease recurrence, results from tests in mice can translate to novel treatment approaches for individual cancer patients.
Latest:
Developments in Metastatic CancerOver the past several years, several new approaches to treatment have prolonged and improved quality of life for patients with metastases.
Latest:
Promoting Sleep in Children With CancerRebecca Kronk, PhD, CRNP, MSN, writes about evidence recognizing sleep disturbances and fatigue as common occurrences in children with cancer during treatment, after treatment, and in long-term survivors.
Latest:
Measuring Quality Cancer CareThe lack of attention in systematically measuring quality and value in cancer care became particularly obvious when working with the Oncology Medical Home Steering Committee on its objective of defining 16 quality, value, and outcome measures for cancer care.
Latest:
The Right System for the Right Price: To Avoid EHR Sticker Shock, You Have to See the Big PictureThe decision to move from a paper-based oncology practice to one based on an EHR system can be onerous and intimidating.
Latest:
Key Features of the CMMI Oncology Care Model (OCM)To date, enthusiasm for bundled pricing has consisted principally of cardiac and orthopedic procedures with a hospital inpatient component. Is oncology next in line for alternate/bundled payment?
Latest:
Synchronous Radiotherapy With Chemotherapy Improves Local Control in Early Breast Cancer PatientsRadiotherapy can be given between or during chemotherapy cycles, rather than sequentially, for women with early breast cancer.
Latest:
Advances in Preventing and Diagnosing Cervical CancerAdvances in screening and the approval of vaccines against the human papillomavirus (HPV), which causes 70% of cervical cancer cases, have brought us to a turning point with cervical cancer.
Latest:
Nurses Leading the Way: Promoting Adherence to Oral Cancer MedicationsSandra Spoelstra, PhD, RN, of the Michigan State University College of Nursing, outlines the essential and growing role of oncology nurses in helping patients with cancer to manage their oral regimens
Latest:
Complexities of Translating PD-1/PD-L1 Agents to Clinical Practice EmergeAs varying immunotherapy options become available for different types of cancers, researchers will have to take the next steps in clinical studies and in practice before the growing excitement over emerging agents can truly be translated into beneficial new therapies for patients.
Latest:
Experts Discuss New Diagnostic and Management Approaches in Multiple MyelomaWith the advent of safer and more effective treatments, early diagnosis of multiple myeloma (MM) has become an important goal.
Latest:
Reimbursement and Managed Care News: June 2007Topics covered in this issue include: 1) High Cancer Drug Costs Altering the Research and Treatment Dynamic 2) $128 Million Settlement to Physicians 3) Coinsurance Change for Medicare Beneficiaries for Colon Cancer Screening, and more
Latest:
The Value of Office-Based Prescription DispensingSteve Dobbs, the CEO of Urologic Specialists of Oklahoma, Inc, discusses the viability, legality, and successful implementation of an office-based medication-dispensing solution.
